Literature DB >> 22577619

Alternative therapies in Staphylococcus aureus diseases.

Julianna Kurlenda1, Mariusz Grinholc.   

Abstract

Staphylococcus aureus is a common pathogen responsible for health-care-associated infections as well as community acquired ones. It is the etiological factor of a wide spectrum of infections. Therapeutic problems are caused by resistance of S. aureus to many antibiotics, specifically to methicillin (methicillin-resistant S. aureus, MRSA). In such cases a limited spectrum of antibiotics may be used and prolonged hospitalization is costly. Hence, there is an urgent need for the development of alternative antibiotic therapeutics. This work reviews the current knowledge concerning prospective treatment of staphylococcal diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577619

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  19 in total

1.  Sulfide Protects Staphylococcus aureus from Aminoglycoside Antibiotics but Cannot Be Regarded as a General Defense Mechanism against Antibiotics.

Authors:  Julia Weikum; Niklas Ritzmann; Nils Jelden; Anna Klöckner; Sebastian Herkersdorf; Michaele Josten; Hans-Georg Sahl; Fabian Grein
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.

Authors:  D R Alves; A Gaudion; J E Bean; P Perez Esteban; T C Arnot; D R Harper; W Kot; L H Hansen; M C Enright; A Tobias A Jenkins
Journal:  Appl Environ Microbiol       Date:  2014-08-22       Impact factor: 4.792

3.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

Review 4.  Nanobiosystems for Antimicrobial Drug-Resistant Infections.

Authors:  Foteini Gkartziou; Nikolaos Giormezis; Iris Spiliopoulou; Sophia G Antimisiaris
Journal:  Nanomaterials (Basel)       Date:  2021-04-22       Impact factor: 5.076

5.  Potential therapeutic drug target identification in Community Acquired-Methicillin Resistant Staphylococcus aureus (CA-MRSA) using computational analysis.

Authors:  Pramod Kumar Yadav; Gurmit Singh; Satendra Singh; Budhayash Gautam; Esmaiel If Saad
Journal:  Bioinformation       Date:  2012-07-21

6.  The photodynamic antibacterial effects of silicon phthalocyanine (Pc) 4.

Authors:  Matthew L Dimaano; Chantal Rozario; Michelle M Nerandzic; Curtis J Donskey; Minh Lam; Elma D Baron
Journal:  Int J Mol Sci       Date:  2015-04-08       Impact factor: 5.923

Review 7.  Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus.

Authors:  Piotr Szweda; Marta Schielmann; Roman Kotlowski; Grzegorz Gorczyca; Magdalena Zalewska; Slawomir Milewski
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-18       Impact factor: 4.813

8.  Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.

Authors:  Latre Buntaran; Mochammad Hatta; Andi R Sultan; Ressy Dwiyanti; Muhammad Sabir
Journal:  BMC Res Notes       Date:  2013-03-23

9.  Efficacy of Caltropis procera and Ficus sycomorus extracts in treating MRSA (methicillin-resistant Staphylococcus aureus)-keratitis in rabbit.

Authors:  Waiel F Sayed; Wesam M A Salem; Mohie A M Haridy; Ne'mat H Hassan
Journal:  EXCLI J       Date:  2015-06-16       Impact factor: 4.068

10.  Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B.

Authors:  Piotr Szweda; Marta Schielmann; Aneta Frankowska; Barbara Kot; Magdalena Zalewska
Journal:  J Vet Med Sci       Date:  2013-11-11       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.